Top Page
Bodycote
(LSE:BOY)
Bodycote (BOY) vs. S&P 500 (SPY)
Bodycote Business Overview & Revenue Model
Bodycote Financial Statement Overview
| Breakdown | ||||
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 802.50M | 743.60M | 615.80M | 598.00M | 719.70M | Gross Profit |
| 108.10M | 269.70M | 225.70M | 186.90M | 261.00M | EBIT |
| 119.20M | 94.90M | 80.20M | 57.70M | 116.40M | EBITDA |
| 201.70M | 186.60M | 167.70M | 97.00M | 212.70M | Net Income Common Stockholders |
| 85.60M | 73.70M | 59.50M | 400.00K | 93.80M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 45.20M | 37.20M | 39.30M | 30.70M | 22.00M | Total Assets |
| 1.14B | 1.17B | 1.07B | 1.11B | 1.03B | Total Debt |
| 96.90M | 136.60M | 156.20M | 128.80M | 80.50M | Net Debt |
| 51.70M | 99.40M | 116.90M | 98.10M | 58.50M | Total Liabilities |
| 344.40M | 385.70M | 384.40M | 428.60M | 321.30M | Stockholders Equity |
| 790.80M | 780.90M | 684.70M | 680.50M | 705.00M |
| Cash Flow | Free Cash Flow | |||
| 109.20M | 70.10M | 87.10M | 74.50M | 94.10M | Operating Cash Flow |
| 191.60M | 137.10M | 139.10M | 134.40M | 172.80M | Investing Cash Flow |
| -71.20M | -62.30M | -104.80M | -124.70M | -90.40M | Financing Cash Flow |
| -110.20M | -76.60M | -24.80M | -1.30M | -97.60M |
Bodycote Technical Analysis
Bodycote Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | £2.15B | 4.42 | 21.80% | 5.97% | -15.51% | 200.70% | |
67 Neutral | £4.19B | 26.42 | 6.84% | 3.69% | -3.92% | -7.30% | |
65 Neutral | £543.45M | 10.97 | 14.06% | 6.15% | -1.26% | 6.56% | |
64 Neutral | £864.68M | 45.30 | 2.74% | 4.81% | -5.66% | -76.42% | |
63 Neutral | $4.21B | 11.55 | 5.28% | 250.72% | 4.13% | -9.42% | |
63 Neutral | £742.78M | 43.17 | 3.58% | 7.17% | -5.21% | -72.13% | |
58 Neutral | £25.37M | ― | -44.37% | ― | -8.33% | 74.38% |
Bodycote Corporate Events
Bodycote plc announced the continuation of its share buyback programme, purchasing 37,485 ordinary shares at an average price of 482.8736 pence per share. This move is part of an extended programme aimed at reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares and enhancing shareholder value. Following this transaction, Bodycote has a total of 179,142,288 ordinary shares in issue, with no shares held in treasury. This strategic financial maneuver is expected to strengthen Bodycote’s market position and demonstrate its commitment to returning value to shareholders.
Spark’s Take on GB:BOY Stock
According to Spark, TipRanks’ AI Analyst, GB:BOY is a Neutral.
Bodycote’s overall stock score reflects a cautious outlook. The company’s strong cash flow and strategic share buyback program are positive aspects. However, financial pressures from declining profitability and increased leverage, along with bearish technical indicators, weigh on the score. High P/E ratio suggests potential overvaluation, mitigated by a solid dividend yield.
To see Spark’s full report on GB:BOY stock, click here.
Bodycote plc has announced the purchase and cancellation of 177,715 of its ordinary shares as part of its extended share buyback programme. This move is part of a broader strategy to manage the company’s capital structure, having acquired a total of 12,276,399 shares since March 2024, which may impact shareholder value and market perception.
Spark’s Take on GB:BOY Stock
According to Spark, TipRanks’ AI Analyst, GB:BOY is a Neutral.
Bodycote’s overall stock score reflects a cautious outlook. The company’s strong cash flow and strategic share buyback program are positive aspects. However, financial pressures from declining profitability and increased leverage, along with bearish technical indicators, weigh on the score. High P/E ratio suggests potential overvaluation, mitigated by a solid dividend yield.
To see Spark’s full report on GB:BOY stock, click here.
Bodycote PLC announced that its Chief Financial Officer, Ben Fidler, has exercised shares under the Bodycote Incentive Plan. A total of 63,906 shares were exercised, with 29,835 shares sold to cover tax liabilities and 34,071 shares retained. This transaction reflects the company’s ongoing commitment to aligning executive interests with shareholder value, potentially impacting its market positioning and stakeholder confidence.
Spark’s Take on GB:BOY Stock
According to Spark, TipRanks’ AI Analyst, GB:BOY is a Neutral.
Bodycote’s overall stock score reflects a cautious outlook. The company’s strong cash flow and strategic share buyback program are positive aspects. However, financial pressures from declining profitability and increased leverage, along with bearish technical indicators, weigh on the score. High P/E ratio suggests potential overvaluation, mitigated by a solid dividend yield.
To see Spark’s full report on GB:BOY stock, click here.
Bodycote PLC announced that its CEO, Jim Fairbairn, exercised shares from the Bodycote Incentive Plan granted in 2024. The transaction involved exercising 94,139 shares, with 43,949 sold to cover tax liabilities and 50,190 retained, highlighting a strategic financial decision by the company’s leadership.
Spark’s Take on GB:BOY Stock
According to Spark, TipRanks’ AI Analyst, GB:BOY is a Neutral.
Bodycote’s overall stock score reflects a cautious outlook. The company’s strong cash flow and strategic share buyback program are positive aspects. However, financial pressures from declining profitability and increased leverage, along with bearish technical indicators, weigh on the score. High P/E ratio suggests potential overvaluation, mitigated by a solid dividend yield.
To see Spark’s full report on GB:BOY stock, click here.
Bodycote plc has announced the performance targets for its Bodycote Incentive Plan (BIP) for 2025, following the release of its 2024 Annual Report. The targets include metrics for Return on Capital Employed, Earnings Per Share growth, and CO2 emissions reduction, reflecting the company’s commitment to financial performance and sustainability goals. These measures are expected to align with Bodycote’s strategic objectives and enhance its market position, potentially impacting shareholder value and environmental performance.
Spark’s Take on GB:BOY Stock
According to Spark, TipRanks’ AI Analyst, GB:BOY is a Neutral.
Bodycote faces financial pressures with declining profitability and increased leverage, but maintains strong cash flow. Technical indicators suggest bearish momentum, impacting short-term performance. The stock’s high P/E ratio indicates potential overvaluation, though the dividend yield and share buyback program provide positive offsets. The overall stock score reflects these mixed factors, suggesting a cautious outlook.
To see Spark’s full report on GB:BOY stock, click here.
Bodycote plc has released its 2024 Annual Report and Accounts along with the notice for the 2025 Annual General Meeting. These documents are available for inspection on the National Storage Mechanism and the company’s website. The announcement underscores Bodycote’s commitment to transparency and regulatory compliance, potentially impacting investor confidence and stakeholder engagement.
Spark’s Take on GB:BOY Stock
According to Spark, TipRanks’ AI Analyst, GB:BOY is a Neutral.
Bodycote’s overall stock score is moderate. The company faces financial pressures with declining profitability and increased leverage, yet maintains strong cash flow. The technical indicators suggest bearish momentum, which could affect near-term performance. While the P/E ratio indicates potential overvaluation, the dividend yield and strategic share buyback efforts provide positive offsets. Investors should monitor for improvements in financial performance and market trends.
To see Spark’s full report on GB:BOY stock, click here.
Bodycote plc has announced the purchase of 43,776 of its own ordinary shares as part of its extended share buyback programme, with the intention to cancel these shares. This move is part of a broader strategy to manage the company’s capital structure and enhance shareholder value, reflecting confidence in its financial position and future prospects.
Spark’s Take on GB:BOY Stock
According to Spark, TipRanks’ AI Analyst, GB:BOY is a Neutral.
Bodycote’s overall stock score is moderate. The company faces financial pressures with declining profitability and increased leverage, yet maintains strong cash flow. The technical indicators suggest bearish momentum, which could affect near-term performance. While the P/E ratio indicates potential overvaluation, the dividend yield and strategic share buyback efforts provide positive offsets. Investors should monitor for improvements in financial performance and market trends.
To see Spark’s full report on GB:BOY stock, click here.
Bodycote plc has announced a continuation of its share buyback programme, purchasing 43,525 of its ordinary shares at prices ranging from 455.4p to 482.2p per share. This move is part of an extended programme that began in December 2024, with the company having bought a total of 11,796,983 shares since March 2024. The purchased shares will be canceled, reducing the total number of shares in issue to 179,659,189, which could potentially enhance shareholder value by increasing earnings per share.
Spark’s Take on GB:BOY Stock
According to Spark, TipRanks’ AI Analyst, GB:BOY is a Neutral.
Bodycote’s overall stock score reflects a moderate position. The company faces financial pressures with declining profitability and increased leverage, yet maintains strong cash flow. Technical indicators suggest bearish momentum. While the P/E ratio indicates potential overvaluation, the dividend yield and strategic share buyback efforts provide some positive offsets.
To see Spark’s full report on GB:BOY stock, click here.
Bodycote plc has announced the purchase of 44,761 of its ordinary shares as part of its extended share buyback program. This move, which is part of a larger strategy that has seen the company repurchase over 11 million shares since March 2024, aims to reduce the number of shares in circulation, potentially enhancing shareholder value and reflecting confidence in the company’s financial health.
Spark’s Take on GB:BOY Stock
According to Spark, TipRanks’ AI Analyst, GB:BOY is a Neutral.
Bodycote’s stock score is moderate, reflecting mixed financial performance and technical weakness. The strong cash flow and strategic buyback program are positive factors, but increased leverage and declining profitability pose risks. Additionally, the stock’s high P/E ratio indicates possible overvaluation, which could be a concern for investors.
To see Spark’s full report on GB:BOY stock, click here.
Bodycote PLC has announced a change in the breakdown of its voting rights, with The Goldman Sachs Group, Inc. now holding an 8.001455% stake in the company. This adjustment in voting rights, as reported on April 4, 2025, reflects a slight increase from the previous position and may influence the company’s strategic decisions and stakeholder dynamics.
Bodycote plc has announced the continuation of its share buyback program, purchasing 40,000 ordinary shares at prices ranging from 481.4p to 520.5p per share. This move is part of an extended program initiated in December 2024, aiming to enhance shareholder value by reducing the number of shares in circulation, thereby increasing the value of remaining shares. The company has purchased a total of 11,576,307 shares since March 2024, reflecting its commitment to returning capital to shareholders.
Bodycote plc has announced the continuation of its share buyback program, purchasing 32,419 ordinary shares at an average price of 560.4150 pence per share. This move is part of an extended program initiated in December 2024, with the company having bought a total of 11,466,307 ordinary shares since March 2024. The cancellation of these shares will reduce the total number of shares in issue to 179,989,865, potentially increasing shareholder value and consolidating the company’s market position.
Bodycote plc has announced the purchase of 35,000 of its ordinary shares as part of its extended share buyback programme, with plans to cancel these shares. This move is part of a broader strategy to manage its capital structure, having repurchased a total of 11,433,888 shares since March 2024, reflecting the company’s commitment to enhancing shareholder value.
Bodycote plc has announced the continuation of its share buyback program, purchasing 32,358 ordinary shares at a volume-weighted average price of 572.3309 pence per share. This move is part of the extended program initiated in December 2024, and the company intends to cancel these shares, reducing the total number of shares in issue to 180,107,323. This strategic action reflects Bodycote’s commitment to optimizing its capital structure and potentially enhancing shareholder value.
Bodycote plc has announced the continuation of its share buyback program, purchasing 25,711 ordinary shares through HSBC Bank PLC as part of an extended initiative. This strategic move, which involves canceling the acquired shares, aims to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
Bodycote plc has announced the continuation of its share buyback program, purchasing 21,402 of its ordinary shares at an average price of 567.7881 pence per share. This move is part of an extended program that began in December 2024, with the company having acquired a total of 11,290,780 shares since March 2024. The cancellation of these shares will reduce the total number of shares in issue, potentially increasing the value of remaining shares and demonstrating the company’s commitment to returning value to shareholders.
Bodycote plc has announced the continuation of its share buyback program, purchasing 30,588 ordinary shares at prices ranging from 557.0p to 571.0p per share. This move is part of an extended program that began in December 2024, with the company having acquired a total of 11,269,378 shares since March 2024. The cancellation of these shares will reduce the total number of shares in issue, potentially increasing the value for remaining shareholders.
Bodycote PLC, a UK-based company, has experienced a change in the voting rights distribution as reported by The Goldman Sachs Group, Inc. The notification indicates that Goldman Sachs now holds a total of 8.000080% of voting rights in Bodycote, up from a previous position of 7.158152%. This change signifies a notable increase in Goldman Sachs’ influence within the company, potentially impacting Bodycote’s strategic decisions and stakeholder dynamics.
Bodycote plc has announced the continuation of its share buyback program, purchasing 43,875 of its ordinary shares through HSBC Bank PLC. This move is part of an extended program that has seen the company buy back a total of 11,024,355 shares since March 2024. The company intends to cancel the purchased shares, which will affect the total number of voting rights, now standing at 180,431,817 shares. This strategic financial maneuver is aimed at optimizing the company’s capital structure and potentially enhancing shareholder value.
Bodycote plc has announced the purchase of 63,017 of its ordinary shares as part of an extended share buyback programme, with the intention to cancel these shares. This move is part of a larger strategy, having bought a total of 10,915,782 shares since March 2024, aimed at optimizing the company’s capital structure and potentially enhancing shareholder value.
Bodycote plc has announced the purchase of 42,979 of its ordinary shares as part of its extended share buyback programme. This move, which involves canceling the purchased shares, reduces the total number of shares in issue to 180,999,119, potentially increasing shareholder value and demonstrating confidence in the company’s financial health.
Bodycote has announced a new divisional reporting structure, effective for its 2024 results, which reorganizes its operations into two main technology-focused divisions: Specialist Technologies and Precision Heat Treatment. This strategic change aims to optimize operations, enhance margins, and expand market reach by focusing on high-quality and technology-driven services, with an interim non-core division to aid in the transition.
Bodycote plc announced the continuation of its share buyback programme, purchasing 41,308 ordinary shares at prices ranging from 664.0p to 673.0p per share. This move, part of an extended programme that commenced in December 2024, reflects Bodycote’s strategy to manage its capital structure and return value to shareholders, potentially impacting its market positioning by reducing the number of shares in circulation.
Bodycote plc announced the purchase of 60,431 of its ordinary shares as part of its extended share buyback program. The company intends to cancel these shares, reducing the total number of shares in issue to 181,530,845, which reflects the total number of voting rights. This move is part of a broader strategy that has seen Bodycote buy back a total of 9,925,327 shares since March 2024, potentially enhancing shareholder value and signaling confidence in its financial stability.
Bodycote plc, a company specializing in thermal processing services, has announced the continuation of its share buyback program. On February 11, 2025, the company purchased 54,714 ordinary shares, which will be canceled, reducing the total number of shares in circulation to 181,664,946. This move is part of an extended share buyback program that began in March 2024, through which Bodycote has acquired a total of 9,791,226 ordinary shares. The cancellation of shares is intended to enhance shareholder value by reducing the number of shares available in the market.